Brain scans and blood tests for Alzheimer's disease
Part of Brain & nervous system clinical trials.
This study uses a special brain scan (PET imaging) and blood tests to look for early signs of Alzheimer's and other brain diseases. It aims to improve how we detect and understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are from a family with a known inherited form of Alzheimer's disease, OR you are being seen at a memory clinic for mild memory problems or Alzheimer's, OR you are a healthy older adult with no memory issues.
- You do not have cancer or any other serious disease that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This study tests a new type of brain scan ([18F]F-AraG PET) that may help detect Alzheimer's disease earlier or more accurately. Researchers will take pictures of your brain to see if this scan can identify changes related to Alzheimer's.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.